Being With the Patient: The Use of Clinical Evidence, ReconsideredHARPER, Gordon; BECKER, Daniel F; COPANS, Stuart A et al.The Journal of nervous and mental disease. 2013, Vol 201, Num 9, pp 813-817, issn 0022-3018, 5 p.Article

New drug approval times and clinical evidence in JapanONO, Shunsuke; YOSHIOKA, Chisato; ASAKA, One et al.Contemporary clinical trials. 2005, Vol 26, Num 6, pp 660-672, issn 1551-7144, 13 p.Article

A survey of abstracts of high-impact clinical journals indicated most statistical methods presented are summary statisticsTABACK, Nathan; KRZYZANOWSKA, Monika K.Journal of clinical epidemiology. 2008, Vol 61, Num 3, pp 277-281, issn 0895-4356, 5 p.Article

Polyanalgesic Consensus Conference 2003: An update on the management of pain by intraspinal drug delivery: Report of an expert panelHASSENBUSCH, Samuel J; PORTENOY, Russell K; LEVY, Robert M et al.Journal of pain and symptom management. 2004, Vol 27, Num 6, pp 540-563, issn 0885-3924, 24 p.Article

The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART studyGORTER, P. M; VISSEREN, F. L. J; ALGRA, A et al.Diabetic medicine. 2007, Vol 24, Num 12, pp 1352-1360, issn 0742-3071, 9 p.Article

Repression and splitting : Towards a method of conceptual comparisonHINSHELWOOD, R. D.International journal of psycho-analysis. 2008, Vol 89, pp 503-521, issn 0020-7578, 19 p., 3Article

BION'S EVIDENCE AND HIS THEORETICAL STYLECIVITARESE, Giuseppe.The Psychoanalytic quarterly. 2013, Vol 82, Num 3, pp 615-633, issn 0033-2828, 19 p.Article

Fibrin(ogen) in cardiovascular disease: an updateKOENIG, Wolfgang.Thrombosis and haemostasis. 2003, Vol 89, Num 4, pp 601-609, issn 0340-6245, 9 p.Article

Pleiotropic Effects of Statins -Clinical EvidenceATHYROS, Vasilios G; KAKAFIKA, Anna I; TZIOMALOS, Konstantinos et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 5, pp 479-489, issn 1381-6128, 11 p.Article